GLP-2T
$119.99
In stock
Dilution notice
If a compound turns cloudy after it is reconstituted, the cause is almost always the reconstitution solution rather than the compound itself, and non-laboratory-grade solutions are the usual culprit. For this reason, cloudiness cannot be accepted as grounds for a refund unless the reconstitution was done using a laboratory-grade reconstitution solution.
Description
Tirzepatide is a dual-agonist research peptide designed to engage both GIP and GLP-1 receptors. Research focuses on how one peptide interacts with two receptor systems and how its structure shapes signaling at each receptor.
Research context
- GIP and GLP-1 receptor engagement1
- How one peptide binds across two receptor systems2
- Structural features that shape receptor signaling3
CAS number 2023788-19-2
- Willard FS, et al. JCI Insight. 2020. DOI:10.1172/jci.insight.140532. PMCID:PMC7526454
- Sun B, et al. Proc Natl Acad Sci USA. 2022. DOI:10.1073/pnas.2116506119
- Zou X, et al. Int J Biol Macromol. 2025. DOI:10.1016/j.ijbiomac.2025.146141
Intended use
Research Use Only. Supplied strictly for laboratory research. Not for use in humans or animals, and not for use in foods, drugs, supplements, or diagnostics.
These statements have not been evaluated by the Food and Drug Administration. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. Use is restricted to qualified research professionals.
Batch Documentation
Independent Testing History
Review the latest independently tested batch records for this compound.
Keep exploring
